Prospeo
Hero Section BackgroundHero Section Background
NUCLIDIUM

NUCLIDIUM Email Formats

Biotechnology ResearchFlag of CHBasel, Basel, Switzerland21-50 Employees

NUCLIDIUM Email Formats

NUCLIDIUM uses 2 email formats. The most common is {first name}.{last name} (e.g., john.doe@nuclidium.com), used 63.2% of the time.

FormatExamplePercentage
{first name}.{last name}
john.doe@nuclidium.com
63.2%
{first initial}.{last name}
j.doe@nuclidium.com
36.8%

Key Contact at NUCLIDIUM

Flag of CH

Leila Jaafar

Ceo And Founder

Company overview

HeadquartersBasel, Basel, Switzerland
Phone number+41783266666
Websites
NAICS541714
Keywords
R&D, Diagnostic Imaging, Molecular Imaging, Radionuclide Production, Precision Oncology, Hybrid Imaging, Therapeutic Imaging, Tracer Development, Targeted Radiotherapy
Founded2017
Employees21-50
Socials

About NUCLIDIUM

Nuclidium is setting a new standard in the precision oncology landscape by developing best-in-class copper-based radiopharmaceuticals that enable the highest accuracy and accessibility for targeted cancer treatment and diagnosis. Our flexible CuTraceTM platform combines copper radiometals with a variety of highly specific cancer-targeting molecules to rapidly develop novel therapeutic and diagnostic programs. The resulting product portfolio leverages the unique properties of copper to achieve an improved safety and efficacy profile with advantageous economics for hospitals and patients. Nuclidium’s differentiated “diagnostic to therapeutic” approach de-risks our development pathway. With innovation as our core, we overcome supply limitations in manufacturing and distribution, bringing greater flexibility to medical facilities. We are a diverse and interdisciplinary team focused on changing precision radio-oncology for the better to deliver a true benefit to cancer patients.

Employees by Management Level

Total employees: 21-50

Seniority

Employees

Entry
Head
C-Suite

Employees by Department

NUCLIDIUM has 10 employees across 6 departments.

Departments

Number of employees

Funding Data

Explore NUCLIDIUM's funding history, including investment rounds, total capital raised, and key backers.

Funding Date
Round
Amount
Link to Article
2022-04-299$2,600,000

Funding Insights

$2,600,000

Total funding amount

$2,600,000

Most recent funding amount

1

Number of funding rounds

NUCLIDIUM Tech Stack

Discover the technologies and tools that power NUCLIDIUM's digital infrastructure, from frameworks to analytics platforms.

jQuery UI

jQuery UI

JavaScript libraries

Animate.css

Animate.css

UI frameworks

One.com

One.com

Hosting

Elementor

Elementor

Page builders

Microsoft 365

Microsoft 365

Email

jQuery Migrate

jQuery Migrate

JavaScript libraries

jQuery

jQuery

JavaScript libraries

PHP

PHP

Programming languages

WordPress

WordPress

Blogs

Bootstrap

Bootstrap

UI frameworks

Nginx

Nginx

Reverse proxies

Slider Revolution

Slider Revolution

Photo galleries

Frequently asked questions

NUCLIDIUM is located in Basel, Basel, CH.
You can reach NUCLIDIUM at +41783266666.
NUCLIDIUM was founded in 2017, making it 9 years old. The company has established itself as a significant player in its industry over this time.
NUCLIDIUM has approximately 21-50 employees. The company continues to grow its workforce to support its business operations and expansion.
NUCLIDIUM has raised a total of $2,600,000 across 1 funding rounds. This investment has helped the company grow and expand its operations.

4.8

40,000 users

top 50
high performer
most used
tier 1 accuracy

Build leads list with verified emails & mobiles